Brief: Biotech Firm NeuroSense Collaborates With Lonza To Identify Exosome-based Biomarkers

Neurosense Therapeutics

09/04/2024 13:39

April 9 (Reuters) - Lonza and NeuroSense Therapeutics:
    * NEUROSENSE THERAPEUTICS: COLLABORATION WITH LONZA TO
EVALUATE
BIOLOGICAL CHANGES OCCURRING IN PEOPLE WITH NEURODEGENERATIVE
DISEASES, INCLUDING ALS

Source text for Eikon:  ID:nPn1rPMXFa 

 ((Reuters.Briefs@thomsonreuters.com;))